Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Apex Neuro
AddedFeb 17, 2024
UpdatedJun 18, 2026
Apex Neuro

Apex Neuro

Series A

Apex Neuro: A disruptive tech firm innovating personal and medical wearables for daily wellness, backed by renowned VC firms.

HQ
Boston, MA, US
Founded
2015
Overview
Compare
Fundraising
Employees

Apex Neuro is an innovative life sciences company developing a disruptive new category of personal and medical wearables to improve how we feel, every day.

Backed by major VC firms and with offices in Cambridge, MA and in New York City, APEX NEURO is founded on science from Harvard Medical School

Apex Neuro - Similar Companies

Nesos logo

Nesos

nesos.com

DaVinci Wearables logo

DaVinci Wearables

Neuro42 logo

Neuro42

Epic Neuro logo

Epic Neuro

Feelmore Labs logo

Feelmore Labs

Neurava logo

Neurava

Invicta Medical logo

Invicta Medical

Neurvana Medical logo

Neurvana Medical

BrainHealth logo

BrainHealth

neuromore logo

neuromore

neuromore.com

Neuraly logo

Neuraly

neuralymed.com

BrainCo logo

BrainCo

brainco.tech

Empatica logo

Empatica

empatica.com

NeuroX Innovations logo

NeuroX Innovations

Q'Apel Medical logo

Q'Apel Medical

qapelmedical.com

Apex Neuro - Quick Facts

Who are Apex Neuro's competitors?

Companies similar to Apex Neuro include Nesos, DaVinci Wearables, Neuro42 and Epic Neuro.

When was Apex Neuro founded?

Apex Neuro was founded in 2015.

Where is Apex Neuro's headquarters located?

Apex Neuro's headquarters is located in Boston, MA, US.

When was Apex Neuro's last funding round?

Apex Neuro's most recent funding round was for $4M (USD) in March 2022.

How much has Apex Neuro raised to-date?

As of Mar 23, 2022, Apex Neuro has raised a total of $4M (USD).

How many employees does Apex Neuro have?

Apex Neuro has 30 employees as of Feb 4, 2024.

Apex Neuro - Classification

Ownership
  • Venture Capital
Technology
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Medical Wearables
Tags
  • Hardware
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified